Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN Registry.

"Disclosures Dr Postma received grants from Siemens, Bayer. Dr Yoo received grants from Medtronic, Ceronovus, Penumbra, Stryker, personal fees from Ceronovus, Penumbra, Vesalio, and equity ownership interest from Insera Therapeutics. Dr van der Lugt received grants from CVON/Dutch Heart Foundation, Brain Foundation, Stryker, Medtronic, Ceronovus, Penumbra. Dr van der Worp received grants from Stryker, personal fees from Bayer, LivaNova. Dr Majoie received grants from CVON/Dutch Heart Foundation, Stryker, European Commission, TWIN, Dutch Health Evaluation Program and is shareholder of Nico.Lab. Dr Dippel received grants from Dutch Heart Foundation, Brain Foundation Netherlands, The Netherlands Organisation for Health Research and Development, Health Holland Top Sector Life Sciences & Health, Stryker, Penumbra, Inc, Medtronic, Thrombolytic Science LLC, Ceronovus. Dr Boogaarts received personal fees from Stryker. Dr Coutinho received grants from Boehringer Ingelheim, Bayer, Medtronic. Dr van Doormaal received other view from Stryker). Dr van den Berg received other view from Ceronovus. Dr van Zwam received personal fees from Ceronovus, Stryker. Dr Roos is a shareholder at Nico.Lab. The other authors report no conflicts."

"Sources of Funding This study was funded and carried out by the Erasmus University Medical Centre, Amsterdam University Medical Centers location Academic Medical Center, and Maastricht University Medical Centre. The study was additionally funded by the Applied Scientific Institute for Neuromodulation (Toegepast Wetenschappelijk Instituut voor Neuromodulatie), which played no role in trial design and patient enrollment, nor in data collection, analysis, or writing of the article."